Guggenheim Increases Medpace (NASDAQ:MEDP) Price Target to $464.00

Medpace (NASDAQ:MEDP – Get Free Report) had its price target lifted by research analysts at Guggenheim from $453.00 to $464.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Guggenheim’s price objective indicates a potential upside of 17.34% from the company’s […]

Related Keywords

United States , America , Susane Burwig , Robertw Baird , , Schulhoff Co , Deutsche Bank Aktiengesellschaft , Medpace Investors Llc , Miller Howard Investments Inc , Arcadia Investment Management Corp , Coldstream Capital Management Inc , Medpace Holdings Inc , Jefferies Financial Group , Get Free Report , Bank Aktiengesellschaft , Medpace Investors , Investment Management Corp , Howard Investments , Capital Management , North America , Medpace Daily ,